EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prostate Cancer Recurrence Mimicking a Primary Paranasal Sinus Tumor on 18 F‐FDG PET/CT During Treatment for Metastases After 10 Years of Remission

Kohei Suzuki iD, Kazuyuki Ogawa, Naohiro Makise iD, Hiromasa Kurosaki iD, Hiroyuki Funatsu iD, Junpei Kuyama

Case Reports in Radiology · 2026-01 · 2026 (1)

DOI: 10.1155/crra/2643786 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Case Reports in Radiology, online erschienen am 07.08.2026. Verfasst von Kohei Suzuki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Imaging, Chiba Cancer Center, Chiba, Japan, uicc.org. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastatic tumors of the nasal cavity and paranasal sinuses are rare, and the prostate is a particularly uncommon primary site. Including metastatic prostate cancer in the differential diagnosis of sinonasal tumors can be clinically challenging. To our knowledge, there are no detailed case reports confirming uptake in paranasal sinus metastases from prostate cancer using 18 F‐fluorodeoxyglucose positron emission tomography/computed tomography (FDG‐PET/CT). The patient was a 68‐year‐old man who was diagnosed with prostate cancer 16 years prior to his visit. After a 10‐year remission, he received radiation therapy and radium‐223 for prostate cancer 6 years earlier, followed by multiple courses of radiation therapy for lymph node and bone metastases over the next 5 years. His chief complaints were a 2‐month history of nasal congestion and a postnasal drip. The tumor was located mainly in the right paranasal sinus and showed signs of bone infiltration and tumor necrosis. FDG‐PET/CT showed intense uptake in the mass (maximum standardized uptake value = 15.2). The differential diagnosis included primary and metastatic tumors. Biopsy revealed histological features similar to the primary prostate cancer site from 16 years prior, with prostatic acid phosphatase and NKX3.1 positive staining. The patient was diagnosed with metastatic prostate cancer, underwent palliative radiotherapy, and passed away approximately 23 months after the detection of paranasal sinus metastasis. This case highlights the importance of considering metastasis even in atypical lesions in patients with prostate cancer.

Autor:innen und Institutionen

  • Department of Diagnostic Imaging, Chiba Cancer Center, Chiba, Japan, uicc.org.
  • Department of Nuclear Medicine, Chiba Cancer Center, Chiba, Japan, uicc.org.
  • Department of Surgical Pathology, Chiba Cancer Center, Chiba, Japan, uicc.org.
  • Department of Radiology and Radiation Oncology, Edogawa Hospital, Tokyo, Japan, edogawa.or.jp.

ORCID-Profile: Kohei Suzuki, Naohiro Makise, Hiromasa Kurosaki, Hiroyuki Funatsu

Zitieren

APA

Suzuki, K., Ogawa, K., Makise, N., Kurosaki, H., Funatsu, H., & Kuyama, J. (2026). Prostate Cancer Recurrence Mimicking a Primary Paranasal Sinus Tumor on 18 F‐FDG PET/CT During Treatment for Metastases After 10 Years of Remission. Case Reports in Radiology, 2026(1). https://doi.org/10.1155/crra/2643786

Vancouver

Suzuki K, Ogawa K, Makise N, Kurosaki H, Funatsu H, Kuyama J. Prostate Cancer Recurrence Mimicking a Primary Paranasal Sinus Tumor on 18 F‐FDG PET/CT During Treatment for Metastases After 10 Years of Remission. Case Reports in Radiology. 2026;2026(1). doi:10.1155/crra/2643786

BibTeX
@article{Suzuki2026,
  author = {Suzuki, Kohei and Ogawa, Kazuyuki and Makise, Naohiro and Kurosaki, Hiromasa and Funatsu, Hiroyuki and Kuyama, Junpei},
  title = {Prostate Cancer Recurrence Mimicking a Primary Paranasal Sinus Tumor on 18 F‐FDG PET/CT During Treatment for Metastases After 10 Years of Remission},
  journal = {Case Reports in Radiology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crra/2643786}
}
Kostenlos starten →